SCHEMBL3633495

SCHEMBL3633495

Cc1nc2ccccc2cc1CO

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.58
STAT3 P40763 3/20 0.58
KDM4E B2RXH2 3/20 0.58
HPGD P15428 2/20 0.58
GAA P10253 1/20 0.58
KMT2A Q03164 4/20 0.57
MEN1 O00255 3/20 0.57
CYP1A2 P05177 3/20 0.56
MAPT P10636 4/20 0.46
GLA P06280 1/20 0.46
ACHE P22303 1/20 0.46
HTT P42858 4/20 0.46
SMN1; SMN2 Q16637 4/20 0.46
TDP1 Q9NUW8 1/20 0.44
GPR3 P46089 1/20 0.44
TLR8 Q9NR97 2/20 0.44
GRM1 Q13255 1/20 0.42
LMNA P02545 2/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
POLB P06746 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13029622 0.82 ALDH1A1 (0.55) ALDH1A1STAT3KDM4EHPGDGAA
SCHEMBL8645151 0.81 STAT3 (0.53) ALDH1A1STAT3KDM4EHPGDGAA
SCHEMBL28160291 0.81 STAT3 (0.53) ALDH1A1STAT3KDM4EHPGDGAA
SCHEMBL3641269 0.81 STAT3 (0.53) ALDH1A1STAT3KDM4EHPGDGAA
SCHEMBL3640530 0.81 KMT2A (0.65) ALDH1A1STAT3KDM4EHPGDGAA
Hydrochloric Acid SCHEMBL6991460 0.79 KMT2A (0.62) ALDH1A1STAT3KDM4EHPGDGAA
SCHEMBL24597657 0.79 KDM4E (0.67) ALDH1A1STAT3KDM4EHPGDGAA
SCHEMBL28707205 0.78 ALDH1A1 (0.48) ALDH1A1STAT3KDM4EHPGDGAA
SCHEMBL29370497 0.78 ALDH1A1 (0.48) ALDH1A1STAT3KDM4EHPGDGAA
SCHEMBL7927501 0.78 ALDH1A1 (0.48) ALDH1A1STAT3KDM4EHPGDGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2155751-A1 PYRROLOPYRIMIDIN-7-ONE DERIVATIVES AND THEIR USE AS PHARMACEUTICALS AstraZeneca AB (SE) 2010-02-24 EP disclosed
US-20090099195-A1 Therapeutic Compounds 570 ASTRAZENECA AB (SE) 2009-04-16 US disclosed
WO-2008136756-A1 PYRROLOPYRIMIDIN-7-ONE DERIVATIVES AND THEIR USE AS PHARMACEUTICALS ASTRAZENECA AB (SE) 2008-11-13 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090099195-A1 Therapeutic Compounds 570 OPRL1, OPRK1, OPRM1 ALDH1A1 245/4885STAT3 1462/4885KDM4E 2693/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.